Total Payments
$3,613
2024 Payments
$1,229
Companies
23
Transactions
117
Medicare Patients
8,805
Medicare Billing
$749,548
Payment Breakdown by Category
Food & Beverage$3,331 (92.2%)
Travel$282.52 (7.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,331 | 114 | 92.2% |
| Travel and Lodging | $282.52 | 3 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $843.42 | 12 | $0 (2024) |
| Boston Scientific Corporation | $735.68 | 11 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $390.33 | 18 | $0 (2024) |
| PFIZER INC. | $248.44 | 12 | $0 (2024) |
| Abbott Laboratories | $184.69 | 5 | $0 (2024) |
| Amgen Inc. | $145.11 | 6 | $0 (2024) |
| Medtronic Vascular, Inc. | $144.57 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $139.28 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $128.97 | 6 | $0 (2024) |
| Lantheus Medical Imaging, Inc. | $116.70 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,229 | 32 | Medtronic, Inc. ($578.04) |
| 2023 | $487.72 | 17 | Medtronic, Inc. ($228.07) |
| 2022 | $189.21 | 10 | Merck Sharp & Dohme LLC ($52.74) |
| 2021 | $74.67 | 4 | Janssen Pharmaceuticals, Inc ($24.15) |
| 2020 | $81.75 | 5 | PFIZER INC. ($34.36) |
| 2019 | $543.41 | 15 | Boston Scientific Corporation ($263.98) |
| 2018 | $456.08 | 14 | BOSTON SCIENTIFIC CORPORATION ($255.45) |
| 2017 | $551.00 | 20 | BOSTON SCIENTIFIC CORPORATION ($158.66) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.55 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Genetic Disease | ||||||
| 07/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/05/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $251.00 | General |
| 06/05/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $27.60 | General |
| 06/05/2024 | Medtronic, Inc. | SELECTSECURE (Device) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Leads | ||||||
| 06/05/2024 | Medtronic, Inc. | SELECTSECURE (Device) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Leads | ||||||
| 06/05/2024 | Medtronic, Inc. | SELECTSECURE (Device) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: Leads | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $208.57 | General |
| 05/16/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $59.44 | General |
| 05/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2024 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Food and Beverage | Cash or cash equivalent | $8.80 | General |
| Category: Cardiovascular | ||||||
| 04/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/26/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $85.14 | General |
| Category: Electrophysiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,206 | 2,886 | $736,940 | $170,084 |
| 2022 | 34 | 2,358 | 2,814 | $749,434 | $167,335 |
| 2021 | 36 | 2,194 | 2,762 | $1.1M | $200,834 |
| 2020 | 34 | 2,047 | 2,594 | $1.2M | $211,295 |
Total Patients
8,805
Total Services
11,056
Medicare Billing
$749,548
Procedure Codes
146
All Medicare Procedures & Services
146 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 297 | $106,326 | $29,386 | 27.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 176 | 312 | $74,880 | $20,307 | 27.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 33 | 33 | $43,319 | $13,516 | 31.2% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 25 | 25 | $71,475 | $10,914 | 15.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 76 | 76 | $42,840 | $10,894 | 25.4% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 15 | 15 | $42,750 | $10,445 | 24.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 26 | 44 | $12,802 | $9,227 | 72.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 168 | 169 | $95,264 | $9,031 | 9.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 68 | 121 | $21,373 | $7,633 | 35.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 59 | 60 | $27,120 | $6,373 | 23.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 627 | 777 | $21,756 | $4,744 | 21.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 41 | $14,063 | $3,867 | 27.5% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 13 | 13 | $16,939 | $3,826 | 22.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 25 | 91 | $13,276 | $3,819 | 28.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 23 | 60 | $9,000 | $3,591 | 39.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 89 | 142 | $11,928 | $2,609 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $10,298 | $2,458 | 23.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 62 | 97 | $9,894 | $2,105 | 21.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 34 | 34 | $7,990 | $1,871 | 23.4% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 28 | 41 | $4,709 | $1,566 | 33.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 17 | 17 | $6,596 | $1,542 | 23.4% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 15 | 19 | $4,383 | $1,540 | 35.1% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 11 | 17 | $4,250 | $1,344 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $4,392 | $1,188 | 27.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 19 | 19 | $24,941 | $1,156 | 4.6% |
About Dr. Benjamin Smith, MD
Dr. Benjamin Smith, MD is a Cardiovascular Disease healthcare provider based in N Chelmsford, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922159326.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Smith, MD has received a total of $3,613 in payments from pharmaceutical and medical device companies, with $1,229 received in 2024. These payments were reported across 117 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,331).
As a Medicare-enrolled provider, Smith has provided services to 8,805 Medicare beneficiaries, totaling 11,056 services with total Medicare billing of $749,548. Data is available for 4 years (2020–2023), covering 146 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location N Chelmsford, MA
- Active Since 01/15/2007
- Last Updated 07/31/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1922159326
Products in Payments
- LEQVIO (Drug) $282.02
- ELIQUIS (Drug) $183.25
- GENERAL THERAPIES (Device) $173.79
- WATCHMAN (Device) $149.48
- GENERAL - THERAPIES (Device) $143.38
- GENERAL THERAPIES (Device) $142.88
- VYNDAQEL (Drug) $129.33
- XARELTO (Drug) $128.97
- BRILINTA (Drug) $110.65
- ENTRESTO (Drug) $108.31
- Repatha (Biological) $89.12
- ENSITE (Device) $85.14
- Definity (Drug) $84.23
- VERQUVO (Drug) $71.34
- GENERAL TACHY (Device) $68.56
- CAMZYOS (Drug) $61.69
- LifeVest (Device) $60.59
- Corlanor (Drug) $55.99
- Assurity Pacemaker (Device) $38.25
- RESOLUTE ONYX (Device) $37.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in N Chelmsford
Kirk Macnaught, Md, MD
Cardiovascular Disease — Payments: $3,027
Cardiovascular Disease $3,027
Omar Ali, Md, MD
Cardiovascular Disease — Payments: $2,856
Cardiovascular Disease $2,856
Miret Ibrahim, Md, MD
Cardiovascular Disease — Payments: $1,148
Cardiovascular Disease $1,148
Harsh Sanchorawala, Md, MD
Cardiovascular Disease — Payments: $974.34
Cardiovascular Disease $974.34
Eric Ewald, Md, MD
Cardiovascular Disease — Payments: $928.21
Cardiovascular Disease $928.21
Dr. Arash Tabaee, M.d, M.D
Cardiovascular Disease — Payments: $874.82
Cardiovascular Disease $874.82